Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
- PMID: 35548468
- PMCID: PMC9084182
- DOI: 10.3389/fcimb.2022.853981
Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
Abstract
Panax ginseng, as the king of Chinese herb, has significant therapeutic effects on obesity, type 2 diabetes mellitus, fatty liver disease, colitis, diarrhea, and many other diseases. This review systematically summarized recent findings, which show that ginseng plays its role by regulating gut microbiota diversity, and gut microbiota could also regulate the transformation of ginsenosides. We conclude the characteristics of ginseng in regulating gut microbiota, as the potential targets to prevent and treat metabolic diseases, colitis, neurological diseases, cancer, and other diseases. Ginseng treatment can increase some probiotics such as Bifidobacterium, Bacteroides, Verrucomicrobia, Akkermansia, and reduce pathogenic bacteria such as Deferribacters, Lactobacillus, Helicobacter against various diseases. Meanwhile, Bacteroides, Eubacterium, and Bifidobacterium were found to be the key bacteria for ginsenoside transformation in vivo. Overall, ginseng can regulate gut microbiome diversity, further affect the synthesis of secondary metabolites, as well as promote the transformation of ginsenosides for improving the absorptivity of ginsenosides. This review can provide better insight into the interaction of ginseng with gut microbiota in multiple disorders and ginsenoside transformation.
Keywords: ginseng (Panax ginseng C.A. Meyer); ginsenoside; gisenoside transformation; gut microbiota; multiple disorders.
Copyright © 2022 Chen, Zhang, Liu, Qi, Li, Chen, Huang, Liu, Mi and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Review: Gut microbiota: Therapeutic targets of ginseng polysaccharides against multiple disorders.Int J Biol Macromol. 2025 Jan;287:138527. doi: 10.1016/j.ijbiomac.2024.138527. Epub 2024 Dec 9. Int J Biol Macromol. 2025. PMID: 39662561 Review.
-
The Synergistic Effects of Polysaccharides and Ginsenosides From American Ginseng (Panax quinquefolius L.) Ameliorating Cyclophosphamide-Induced Intestinal Immune Disorders and Gut Barrier Dysfunctions Based on Microbiome-Metabolomics Analysis.Front Immunol. 2021 Apr 22;12:665901. doi: 10.3389/fimmu.2021.665901. eCollection 2021. Front Immunol. 2021. PMID: 33968068 Free PMC article.
-
Effects of fermented ginseng on the gut microbiota and immunity of rats with antibiotic-associated diarrhea.J Ethnopharmacol. 2021 Mar 1;267:113594. doi: 10.1016/j.jep.2020.113594. Epub 2020 Nov 18. J Ethnopharmacol. 2021. PMID: 33217518
-
Comparative Analysis of the Rats' Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity.J Agric Food Chem. 2017 Jan 18;65(2):327-337. doi: 10.1021/acs.jafc.6b04848. Epub 2017 Jan 6. J Agric Food Chem. 2017. PMID: 28025886
-
Gut microbiota: A new key of understanding for Panax notoginseng against multiple disorders and biotransformation.J Ethnopharmacol. 2025 Feb 11;341:119306. doi: 10.1016/j.jep.2024.119306. Epub 2025 Jan 4. J Ethnopharmacol. 2025. PMID: 39761836 Review.
Cited by
-
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9. Chin Med. 2023. PMID: 37749560 Free PMC article. Review.
-
Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review.Nutrients. 2022 May 18;14(10):2111. doi: 10.3390/nu14102111. Nutrients. 2022. PMID: 35631252 Free PMC article.
-
Pharmacokinetic Profiling of Ginsenosides, Rb1, Rd, and Rg3, in Mice with Antibiotic-Induced Gut Microbiota Alterations: Implications for Variability in the Therapeutic Efficacy of Red Ginseng Extracts.Foods. 2023 Dec 1;12(23):4342. doi: 10.3390/foods12234342. Foods. 2023. PMID: 38231867 Free PMC article.
-
Korean Red Ginseng extract treatment prevents post-antibiotic dysbiosis-induced bone loss in mice.J Ginseng Res. 2023 Mar;47(2):265-273. doi: 10.1016/j.jgr.2022.08.006. Epub 2022 Aug 31. J Ginseng Res. 2023. PMID: 36926616 Free PMC article.
-
Ginsenoside Rk3 modulates gut microbiota and regulates immune response of group 3 innate lymphoid cells to against colorectal tumorigenesis.J Pharm Anal. 2024 Feb;14(2):259-275. doi: 10.1016/j.jpha.2023.09.010. Epub 2023 Sep 21. J Pharm Anal. 2024. PMID: 38464791 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical